GW Pharmaceuticals stock rises 10% after beating revenue expectations for marijuana-derived drug

 

GW Pharmaceuticals stock rises 10% after beating revenue expectations for marijuana-derived drug

Analysts surveyed by FactSet had estimated overall earnings of a penny a share on revenue of $47 million … of 14 cents a share on sales of $58.1 million. GW Pharmaceuticals stock has gained 57% this …

More GW Pharmaceuticals stock rises 10% after beating revenue expectations for marijuana-derived drug Videos

Leave a Reply